Driver mutations’ effect in secondary myelofibrosis: an international multicenter study based on 781 patients

被引：0
|
作者：
F Passamonti
B Mora
T Giorgino
P Guglielmelli
M Cazzola
M Maffioli
A Rambaldi
M Caramella
R Komrokji
J Gotlib
J J Kiladjian
F Cervantes
T Devos
F Palandri
V De Stefano
M Ruggeri
R Silver
G Benevolo
F Albano
D Caramazza
E Rumi
M Merli
D Pietra
R Casalone
T Barbui
L Pieri
A M Vannucchi
机构：
[1] University of Insubria,Division of Hematology, Department of Clinical and Experimental Medicine
[2] Ospedale di Circolo,Department of Experimental and Clinical Medicine
[3] ASST Sette Laghi,Department of Oncology and Hematology
[4] Institute of Neurosciences,Department of Hematology and BMT Unit
[5] National Research Council of Italy,Malignant Hematology Department
[6] CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproloiferative,Division of Hematology
[7] Azienda ospedaliera-Universitaria Careggi,Department of Hematology
[8] University of Florence,Department of Oncology and Hematology
[9] Università di Pavia,Department of Oncology and Hematology
[10] University of Milan,Department of Services
[11] ASST Papa Giovanni XXIII,undefined
[12] Department of Oncology and Hematology Ospedale Niguarda Cà Granda,undefined
[13] Moffit Cancer Center,undefined
[14] Stanford University,undefined
[15] Hôpital Saint-Louis et Université Paris Diderot,undefined
[16] Hospital Clínic,undefined
[17] IDIBAPS,undefined
[18] University of Barcelona,undefined
[19] University Hospitals Leuven,undefined
[20] Policlinico S. Orsola-Malpighi,undefined
[21] Institute of Hematology,undefined
[22] Università Cattolica del Sacro Cuore,undefined
[23] Ospedale S. Bortolo,undefined
[24] Weill Cornell Medical College,undefined
[25] Centro Oncologico Ematologico Subalpino (COES),undefined
[26] Department of Oncology and Hematology Università di Bari,undefined
[27] Cytogenetics and Medical Genetics Laboratory,undefined
[28] Ospedale di Circolo,undefined
[29] ASST Sette Laghi,undefined
来源：
Leukemia | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：970 / 973
页数：3
相关论文
共 50 条
  • [1] Driver mutations' effect in secondary myelofibrosis: an international multicenter study based on 781 patients
    Passamonti, F.
    Mora, B.
    Giorgino, T.
    Guglielmelli, P.
    Cazzola, M.
    Maffioli, M.
    Rambaldi, A.
    Caramella, M.
    Komrokji, R.
    Gotlib, J.
    Kiladjian, Jj
    Cervantes, F.
    Devos, T.
    Palandri, F.
    De Stefano, V.
    Ruggeri, M.
    Silver, R.
    Benevolo, G.
    Albano, F.
    Caramazza, D.
    Rumi, E.
    Merli, M.
    Pietra, D.
    Casalone, R.
    Barbui, T.
    Pieri, L.
    Vannucchi, A. M.
    LEUKEMIA, 2017, 31 (04) : 970 - +
  • [2] Driver Mutations and Prognosis in 1118 Patients with Primary Myelofibrosis
    Tefferi, Ayalew
    Guglielmelli, Paola
    Lasho, Terra L.
    Elala, Yoseph
    Fanelli, Tiziana
    Gangat, Naseema
    Finke, Christy
    Rotunno, Giada
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Pardanani, Animesh
    Vannucchi, Alessandro M.
    BLOOD, 2015, 126 (23)
  • [3] CLINICAL EFFECT OF FOUNDING DRIVER MUTATIONS IN PATIENTS WITH PRIMARY MYELOFIBROSIS: A BASIS FOR MOLECULAR CLASSIFICATION AND PROGNOSTICATION
    Rumi, E.
    Pietra, D.
    Guglielmelli, P.
    Martinez-Trillos, A.
    Casetti, I.
    Colomer, D.
    Pieri, L.
    Pratcorona, M.
    Rotunno, G.
    Sant'Antonio, E.
    Bellini, M.
    Cavalloni, C.
    Mannarelli, C.
    Milanesi, C.
    Boveri, E.
    Ferretti, V.
    Pascutto, C.
    Astori, C.
    Rosti, V.
    Cervantes, F.
    Barosi, G.
    Vannucchi, A.
    Cazzola, M.
    HAEMATOLOGICA, 2014, 99 : 529 - 529
  • [4] The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
    P Guglielmelli
    T L Lasho
    G Rotunno
    J Score
    C Mannarelli
    A Pancrazzi
    F Biamonte
    A Pardanani
    K Zoi
    A Reiter
    A Duncombe
    T Fanelli
    D Pietra
    E Rumi
    C Finke
    N Gangat
    R P Ketterling
    R A Knudson
    C A Hanson
    A Bosi
    A Pereira
    R Manfredini
    F Cervantes
    G Barosi
    M Cazzola
    N C P Cross
    A M Vannucchi
    A Tefferi
    Leukemia, 2014, 28 : 1804 - 1810
  • [5] The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
    Guglielmelli, P.
    Lasho, T. L.
    Rotunno, G.
    Score, J.
    Mannarelli, C.
    Pancrazzi, A.
    Biamonte, F.
    Pardanani, A.
    Zoi, K.
    Reiter, A.
    Duncombe, A.
    Fanelli, T.
    Pietra, D.
    Rumi, E.
    Finke, C.
    Gangat, N.
    Ketterling, R. P.
    Knudson, R. A.
    Hanson, C. A.
    Bosi, A.
    Pereira, A.
    Manfredini, R.
    Cervantes, F.
    Barosi, G.
    Cazzola, M.
    Cross, N. C. P.
    Vannucchi, A. M.
    Tefferi, A.
    LEUKEMIA, 2014, 28 (09) : 1804 - 1810
  • [6] The clinical and prognostic relevance of driver mutations in 203 Taiwanese patients with primary myelofibrosis
    Kuo, Ming-Chung
    Lin, Tung-Huei
    Sun, Chien-Feng
    Lin, Tung-Liang
    Wu, Jin-Hou
    Wang, Po-Nan
    Huang, Ying-Jung
    Chang, Hung
    Huang, Ting-Yu
    Shih, Lee-Yung
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (06) : 514 - 521
  • [7] The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis
    Genovese, Elena
    Mirabile, Margherita
    Rontauroli, Sebastiano
    Sartini, Stefano
    Fantini, Sebastian
    Tavernari, Lara
    Maccaferri, Monica
    Guglielmelli, Paola
    Bianchi, Elisa
    Parenti, Sandra
    Carretta, Chiara
    Mallia, Selene
    Castellano, Sara
    Colasante, Corrado
    Balliu, Manjola
    Bartalucci, Niccolo
    Palmieri, Raffaele
    Ottone, Tiziana
    Mora, Barbara
    Potenza, Leonardo
    Passamonti, Francesco
    Voso, Maria Teresa
    Luppi, Mario
    Vannucchi, Alessandro Maria
    Tagliafico, Enrico
    Manfredini, Rossella
    ANTIOXIDANTS, 2022, 11 (01)
  • [8] CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
    A Tefferi
    P Guglielmelli
    T L Lasho
    G Rotunno
    C Finke
    C Mannarelli
    A A Belachew
    A Pancrazzi
    E A Wassie
    R P Ketterling
    C A Hanson
    A Pardanani
    A M Vannucchi
    Leukemia, 2014, 28 : 1494 - 1500
  • [9] CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
    Tefferi, A.
    Guglielmelli, P.
    Lasho, T. L.
    Rotunno, G.
    Finke, C.
    Mannarelli, C.
    Belachew, A. A.
    Pancrazzi, A.
    Wassie, E. A.
    Ketterling, R. P.
    Hanson, C. A.
    Pardanani, A.
    Vannucchi, A. M.
    LEUKEMIA, 2014, 28 (07) : 1494 - 1500
  • [10] Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
    Rumi, Elisa
    Pietra, Daniela
    Pascutto, Cristiana
    Guglielmelli, Paola
    Martinez-Trillos, Alejandra
    Casetti, Ilaria
    Colomer, Dolors
    Pieri, Lisa
    Pratcorona, Marta
    Rotunno, Giada
    Sant'Antonio, Emanuela
    Bellini, Marta
    Cavalloni, Chiara
    Mannarelli, Carmela
    Milanesi, Chiara
    Boveri, Emanuela
    Ferretti, Virginia
    Astori, Cesare
    Rosti, Vittorio
    Cervantes, Francisco
    Barosi, Giovanni
    Vannucchi, Alessandro M.
    Cazzola, Mario
    BLOOD, 2014, 124 (07) : 1062 - 1069
12345